Pulse Biosciences Inc (NASDAQ:PLSE) shares saw strong trading volume on Friday . 1,589,182 shares were traded during mid-day trading, an increase of 991% from the previous session’s volume of 145,607 shares.The stock last traded at $20.10 and had previously closed at $18.18.
Several research analysts recently issued reports on the stock. BidaskClub raised shares of Pulse Biosciences from a “sell” rating to a “hold” rating in a research report on Friday, December 15th. ValuEngine raised shares of Pulse Biosciences from a “sell” rating to a “hold” rating in a research report on Sunday, December 31st.
Pulse Biosciences (NASDAQ:PLSE) last posted its quarterly earnings results on Friday, March 16th. The company reported ($0.53) earnings per share (EPS) for the quarter.
TRADEMARK VIOLATION NOTICE: This article was originally posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this article on another site, it was illegally stolen and republished in violation of U.S. & international copyright and trademark laws. The legal version of this article can be accessed at https://www.tickerreport.com/banking-finance/3355119/pulse-biosciences-plse-sees-strong-trading-volume.html.
Pulse Biosciences Company Profile
Pulse Biosciences, Inc, formerly Electroblate, Inc, is a development-stage medical device company using a platform technology called Nano-Pulse Electro-Signaling (NPES). NPES is a local and drug-free technology that utilizes nanosecond pulsed electric fields to induce cell signaling and the activation of cellular pathways in tissue.
Receive News & Ratings for Pulse Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pulse Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.